PIANO DI SOSTEGNO ALLA RICERCA 2015-2017 - TRANSITION GRANT LINEA 1A PROGETTO "UNIMI PARTENARIATI H2020"

Role of Brain Derived Neurotrophic Factor (BDNF) in anorexia nervosa: pathogenic mechanism and therapeutic potential

PIANO DI SOSTEGNO ALLA RICERCA 2015-2017 - LINEA 2 "DOTAZIONE ANNUALE PER ATTIVITA' ISTITUZIONALE" (ANNO 2016)

Synapse-to-nucleus communication in Alzheimer's disease

Selenium in early life to enhance neurodevelopment in unfavourable settings (SELENIUS)

COLLABORAZIONE SCIENTIFICA NEL SETTORE DEGLI STUDI SPERIMENTALI IN AMBITO CARDIACO AL FINE DI SVILUPPARE RICERCHE NELL'AMBITO DEL DANNO CARDIACO E DELLA TERAPIA RIGENERATIVA CARDIOVASCOLARE NEL MODELLO ANIMALE

Piano integrato di interventi per l'educazione al patrimonio e la didattica museale

Prenylcisteine Lyase as a potential novel player in atherosclerosis

Contribution of lipids and their oxidized metabolites on Arrhythmogenic Cardiomyopathy pathogenesis

Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2017)

Neuroimmunoinfiammazione nel dolore cronico e in un modello transgenico di Alzheimer: alterazioni sensoriali e cognitivo-comportamentali e nuove prospettive terapeutiche

Ricerca sui tumori prostatici indolenti, invasivi e metastatici resistenti alla chemioterapia e al trattamento farmacologico

Dissecting the role of CHD7 and SEMA3A signalling in the control of reproduction and alfaction, which are defective in CHARGE syndrome patients

Patent development of the new modulators of GPR17, a key receptor in remyelinating processes

Approfondimento e modelling dei meccanismi di rimielinizzazione indotti da antimicotici azolici in uso clinico con caratteristiche di riposizionamento.

Proprotein convertase subtilisin/kexin type 9 (PCSK9): a link between lipotoxicity, mitochondrial dysfunction, and frailty-associated heart failure

Studi sui meccanismi molecolari e cellulari alla base della neuropatia trigeminale e della maggiore suscettibilità all'emicrania nella sclerosi multipla

Towards multi-stage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action.

From mother to child health flow: the impact of the endocrine disruptor chemical Bisphenol A (BPA)

Targeting early synaptic dysfunctions induced by alpha-synuclein as a novel therapeutic approach in Parkinson's disease

Risposte maladattative dello stress: studio dei meccanismi che le regolano per identificare nuovi bersagli terapeutici nelle malattie neuropsichiatriche.

Meccanismi di patogenesi negli stadi precoci della malattia di Alzheimer: identificazione di target armacologici e biomarkers

Stress in adolescenza: dalle alterazioni cognitive alla suscettibilità per le patologie psichiatriche.

From RNA to Protein toxicity in motorneuron diseases

An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries (Train2Target)

Useful experimental models for dissecting the molecular links between cancer development/progression and the obesity epidemic

Sensory Processing SensiTivity AND drug Use recovery Pathways (STANDUP)

Dysbindin-antipsychotics psychophamarcogenetics: a mouse-human translational study towards personalized healthcare in bipolar disorders

Combined Next-generation sequencing and in vivo approach to uncover the complex genetic basis of GnRH neuron deficiency

Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2018)

Treating pain to modulate frailty: a bench to bedside mechanism based model

Modulation of bone marrow macrophage plasticity by gametocytes, the transmission stages of malaria parasite

Unveiling the impact of ASGR1 deficiency on the immunoinflammatory signature during atherogenesis (ASGR1 )

Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)

Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS)

Unveiling the role of the Irisin-BNDF axis in controlling muscle to brain metabolic crosstalk in anorexia nervosa

Extracellular vescicles in the pathogenesis of frontotemporal dementia

MicroRNAs in Frailty-Associated Cognitive Impairment (MATCh-In)

Medicina personalizzata per strategie innovative in malattie neuro-psichiatriche e vascolari (PerMedNet)

PCSK9 and cardiac function: bridging cellular lipid metabolism to mitochondrial function and heart failure (PCSK9)